Skip to main content
Log in

Omega-3 fatty acids and heart failure

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

During the past three decades, the protective role of omega (n)-3 polyunsaturated fatty acids (PUFA), mainly eicosapentaenoic acid and docosahexaenoic acid, in patients with coronary heart disease has been widely reported. The Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Heart Failure (GISSI-HF) study, a large-scale clinical trial, recently showed that n-3 PUFA (850–882 mg/d) reduced mortality and admission to the hospital for cardiovascular reasons in patients with chronic heart failure (HF) who were already receiving recommended therapies. The favorable effects of n-3 PUFA in GISSI-HF suggest that marine fish oils could confer protection in HF mainly through their antiarrhythmic action and in part by influencing the mechanisms related to HF progression. This article reviews recent clinical and experimental evidence on the effect of n-3 PUFA in coronary heart disease, with particular attention on HF and its pathophysiologic mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Schocken DD, Benjamin EJ, Fonarow GC, et al.: Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544–2565.

    Article  PubMed  Google Scholar 

  2. Lloyd-Jones DR, Adams R, Carnethonet M, et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21–181.

    Article  PubMed  Google Scholar 

  3. Dickstein K, Cohen-Solal A, Filippatos G, et al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933–989.

    Article  PubMed  Google Scholar 

  4. Cleland JG, Daubert JC, Erdmann E, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539–1549.

    Article  CAS  PubMed  Google Scholar 

  5. Baldasseroni S, Opasich C, Gorini M, et al.: Left bundlebranch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002, 143:398–405.

    Article  PubMed  Google Scholar 

  6. Tavazzi L, Maggioni AP, Marchioli R, et al.: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223–1230.

    Article  PubMed  Google Scholar 

  7. Siddiqui RA, Harvey KA, Zaloga GP: Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 2008, 19:417–437

    Article  CAS  PubMed  Google Scholar 

  8. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354:447–455.

  9. Macchia A, Levantesi G, Franzosi MG, et al.: Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail 2005, 7:904–909.

    Article  CAS  PubMed  Google Scholar 

  10. Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897–1903.

    Article  CAS  PubMed  Google Scholar 

  11. Mozaffarian D, Bryson CL, Lemaitre RN, et al.: Fish intake and risk of incident heart failure. J Am Coll Cardiol 2005, 45:2015–2021.

    Article  CAS  PubMed  Google Scholar 

  12. Yamagishi K, Iso H, Date C, et al.: Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008, 52:988–996.

    Article  CAS  PubMed  Google Scholar 

  13. Yamagishi K, Nettleton JA, Folsom AR: Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008, 156:965–974.

    Article  CAS  PubMed  Google Scholar 

  14. Levitan EB, Wolk A, Mittleman MA: Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J 2009 (epub ahead of print).

  15. Braunwald E, Bristow MR: Congestive heart failure: fifty years of progress. Circulation 2000, 102:IV14–23

    CAS  PubMed  Google Scholar 

  16. Witte KK, Clark AL: Fish oils-adjuvant therapy in chronic heart failure? Eur J Cardiovasc Prev Rehabil 2004, 11:267–274

    Article  PubMed  Google Scholar 

  17. Brouwer IA, Raitt MH, Dullemeijer C, et al.: Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 2009, 30:820–826.

    Article  CAS  PubMed  Google Scholar 

  18. Mozaffarian D, Geelen A, Brouwer IA, et al.: Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 2005, 112:1945–1952.

    Article  CAS  PubMed  Google Scholar 

  19. O’Keefe JH Jr, Abuissa H, Sastre A, et al.: Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006, 97:1127–1130.

    Article  PubMed  Google Scholar 

  20. Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS: Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008, 117:1130–1137.

    Article  CAS  PubMed  Google Scholar 

  21. Mozaffarian D, Prineas RJ, Stein PK, Siscovick DS: Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 2006, 48:478–484.

    Article  CAS  PubMed  Google Scholar 

  22. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al.: Longterm fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—the ATTICA study. Am J Clin Nutr 2007, 85:1385–1391.

    CAS  PubMed  Google Scholar 

  23. Nodari S, Metra M, Milesi G, et al.: The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther 2009, 23:5–15.

    Article  CAS  PubMed  Google Scholar 

  24. Biscione F, Totteri A, De Vita A, et al.: Effect of omega-3 fatty acids on the prevention of atrial arrhythmias. Ital Heart J Suppl 2005, 6:53–59.

    PubMed  Google Scholar 

  25. Calo L, Bianconi L, Colivicchi F, et al.: N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45:1723–1728.

    Article  CAS  PubMed  Google Scholar 

  26. Brouwer IA, Heeringa J, Geleijnse JM, et al.: Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 2006, 151:857–862.

    Article  CAS  PubMed  Google Scholar 

  27. da Cunha DN, Hamlin RL, Billman GE, Carnes CA: n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 2007, 150:281–285.

    Article  PubMed  Google Scholar 

  28. Leon H, Shibata MC, Sivakumaran S, et al.: Effect of fish oil on arrhythmias and mortality: systematic review. BMJ (Clinical Research edition) 2008, 337:a2931.

    Article  Google Scholar 

  29. Yokoyama M, Origasa H, Matsuzaki M, et al.: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090–1098.

    Article  CAS  PubMed  Google Scholar 

  30. Leaf A, Kang JX, Xiao YF: Fish oil fatty acids as cardiovascular drugs. Curr Vasc Pharmacol 2008, 6:1–12.

    Article  CAS  PubMed  Google Scholar 

  31. Verkerk AO, van Ginneken AC, Berecki G, et al.: Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 2006, 70:509–520.

    Article  CAS  PubMed  Google Scholar 

  32. Sarrazin JF, Comeau G, Daleau P, et al.: Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007, 50:1505–1512.

    Article  CAS  PubMed  Google Scholar 

  33. Li Y, Kang JX, Leaf A: Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 1997, 54:511–530.

    Article  CAS  PubMed  Google Scholar 

  34. Takayama K, Yuhki K, Ono K, et al.: Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med 2005, 11:562–566.

    Article  CAS  PubMed  Google Scholar 

  35. Schrepf R, Limmert T, Claus Weber P, et al.: Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004, 363:1441–1442.

    Article  CAS  PubMed  Google Scholar 

  36. Den Ruijter HM, Berecki G, Verkerk AO, et al.: Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 2008, 117:536–544.

    Article  Google Scholar 

  37. Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and benefits. JAMA 2006, 296:1885–1899.

    Article  CAS  PubMed  Google Scholar 

  38. Iso H, Kobayashi M, Ishihara J, et al.: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195–202.

    Article  CAS  PubMed  Google Scholar 

  39. Streppel MT, Ocke MC, Boshuizen HC, et al.: Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 2008, 29:2024–2030.

    Article  PubMed  Google Scholar 

  40. Pepe S, Mclennan PL: Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002, 105:2303–2308.

    Article  CAS  PubMed  Google Scholar 

  41. Pepe S, Mclennan PL: (n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr 2007, 137:2377–2383.

    CAS  PubMed  Google Scholar 

  42. Peoples GE, Mclennan PL, Howe PR, Groeller H: Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008, 52:540–547.

    Article  CAS  PubMed  Google Scholar 

  43. Duda MK, O’shea KM, Tintinu A, et al.: Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 2009, 81:319–327.

    Article  CAS  PubMed  Google Scholar 

  44. Mozaffarian D, Gottdiener JS, Siscovick DS: Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006, 97:216–222.

    Article  PubMed  Google Scholar 

  45. Mclennan PL, Barnden LR, Bridle TM, et al.: Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc Res 1992, 26:871–877.

    Article  CAS  PubMed  Google Scholar 

  46. Vargiu R, Littarru GP, Faa G, Mancinelli R: Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 cardiomyopathic Syrian hamsters. BioFactors (Oxford) 2008, 32:135–144.

    Article  CAS  Google Scholar 

  47. Matsumoto T, Nakayama N, Ishida K, et al.: Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 2009, 329:324–334.

    Article  CAS  PubMed  Google Scholar 

  48. Omura M, Kobayashi S, Mizukami Y, et al.: Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 2001, 487:361–366.

    Article  CAS  PubMed  Google Scholar 

  49. Mori TA, Watts GF, Burke V, et al.: Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000, 102:1264–1269.

    CAS  PubMed  Google Scholar 

  50. Mcveigh GE, Brennan GM, Cohn JN, et al.: Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994, 14:1425–1429.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Marchioli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marchioli, R., Silletta, M.G., Levantesi, G. et al. Omega-3 fatty acids and heart failure. Curr Atheroscler Rep 11, 440–447 (2009). https://doi.org/10.1007/s11883-009-0066-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-009-0066-y

Keywords

Navigation